Global Antibiotic Research and Development Partnership (Gardp)
GARDP is a not-for-profit focused on developing treatments for drug-resistant infections.
🤖
AI Overview
With $60K in lobbying spend across 4 quarterly filings, Global Antibiotic Research and Development Partnership (Gardp) is an active lobbying client. Their lobbying covers 2 issue areas.
$60K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Budget/Appropriations
- •Drug resistance and antibiotic development.
- •FY22 appropriations regarding antibiotic research and development.
- •Antimicrobial resistance; antibiotic research and development.
- •FY 2022 appropriations regarding antibiotic research and development.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.